<MedlineCitation Owner="NLM" Status="MEDLINE">
	<PMID>19754888</PMID>
	<DateCreated>
		<Year>2009</Year>
		<Month>09</Month>
		<Day>16</Day>
	</DateCreated>
	<DateCompleted>
		<Year>2009</Year>
		<Month>11</Month>
		<Day>04</Day>
	</DateCompleted>
	<Article PubModel="Print">
		<Journal>
			<ISSN IssnType="Electronic">1600-065X</ISSN>
			<JournalIssue CitedMedium="Internet">
				<Volume>231</Volume>
				<Issue>1</Issue>
				<PubDate>
					<Year>2009</Year>
					<Month>Sep</Month>
				</PubDate>
			</JournalIssue>
			<Title>Immunological reviews</Title>
			<ISOAbbreviation>Immunol. Rev.</ISOAbbreviation>
		</Journal>
		<ArticleTitle>IP3 receptors: some lessons from DT40 cells.
		</ArticleTitle>
		<Pagination>
			<MedlinePgn>23-44</MedlinePgn>
		</Pagination>
		<Abstract>
			<AbstractText>Inositol-1,4,5-trisphosphate receptors (IP3Rs) are
				intracellular Ca2+ channels that are regulated by IP3 and Ca2+ and
				are modulated by many additional signals. These properties allow
				them to initiate and, via Ca2+-induced Ca2+ release, regeneratively
				propagate Ca2+ signals evoked by receptors that stimulate formation
				of IP3. The ubiquitous expression of IP3R highlights their
				importance, but it also presents problems when attempting to resolve
				the behavior of defined IP3R. DT40 cells are a pre-B-lymphocyte cell
				line in which high rates of homologous recombination afford
				unrivalled opportunities to disrupt endogenous genes. DT40-knockout
				cells with both alleles of each of the three IP3R genes disrupted
				provide the only null-background for analysis of homogenous
				recombinant IP3R. We review the properties of DT40 cells and
				consider three areas where they have contributed to understanding
				IP3R behavior. Patch-clamp recording from the nuclear envelope and
				Ca2+ release from intracellular stores loaded with a low-affinity
				Ca2+ indicator address the mechanisms leading to activation of
				IP(3)R. We show that IP3 causes intracellular IP3R to cluster and
				re-tune their responses to IP3 and Ca2+, better equipping them to
				mediate regenerative Ca2+ signals. Finally, we show that DT40 cells
				reliably count very few IP3R into the plasma membrane, where they
				mediate about half the Ca2+ entry evoked by the B-cell antigen
				receptor.</AbstractText>
		</Abstract>
		<Affiliation>Department of Pharmacology, University of Cambridge,
			Cambridge, UK. cwt1000@cam.ac.uk</Affiliation>
		<AuthorList CompleteYN="Y">
			<Author ValidYN="Y">
				<LastName>Taylor</LastName>
				<ForeName>Colin W</ForeName>
				<Initials>CW</Initials>
			</Author>
			<Author ValidYN="Y">
				<LastName>Rahman</LastName>
				<ForeName>Taufiq</ForeName>
				<Initials>T</Initials>
			</Author>
			<Author ValidYN="Y">
				<LastName>Tovey</LastName>
				<ForeName>Stephen C</ForeName>
				<Initials>SC</Initials>
			</Author>
			<Author ValidYN="Y">
				<LastName>Dedos</LastName>
				<ForeName>Skarlatos G</ForeName>
				<Initials>SG</Initials>
			</Author>
			<Author ValidYN="Y">
				<LastName>Taylor</LastName>
				<ForeName>Emily J A</ForeName>
				<Initials>EJ</Initials>
			</Author>
			<Author ValidYN="Y">
				<LastName>Velamakanni</LastName>
				<ForeName>Saroj</ForeName>
				<Initials>S</Initials>
			</Author>
		</AuthorList>
		<Language>eng</Language>
		<GrantList CompleteYN="Y">
			<Grant>
				<Agency>Biotechnology and Biological Sciences Research Council
				</Agency>
				<Country>United Kingdom</Country>
			</Grant>
			<Grant>
				<Agency>Medical Research Council</Agency>
				<Country>United Kingdom</Country>
			</Grant>
			<Grant>
				<Agency>Wellcome Trust</Agency>
				<Country>United Kingdom</Country>
			</Grant>
		</GrantList>
		<PublicationTypeList>
			<PublicationType>Journal Article</PublicationType>
			<PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
			<PublicationType>Review</PublicationType>
		</PublicationTypeList>
	</Article>
	<MedlineJournalInfo>
		<Country>Denmark</Country>
		<MedlineTA>Immunol Rev</MedlineTA>
		<NlmUniqueID>7702118</NlmUniqueID>
		<ISSNLinking>0105-2896</ISSNLinking>
	</MedlineJournalInfo>
	<ChemicalList>
		<Chemical>
			<RegistryNumber>0</RegistryNumber>
			<NameOfSubstance>Inositol 1,4,5-Trisphosphate Receptors
			</NameOfSubstance>
		</Chemical>
	</ChemicalList>
	<CitationSubset>IM</CitationSubset>
	<MeshHeadingList>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">B-Lymphocytes
			</DescriptorName>
			<QualifierName MajorTopicYN="N">immunology</QualifierName>
			<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="Y">Calcium Signaling
			</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Cell Line
			</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Chickens</DescriptorName>
			<QualifierName MajorTopicYN="N">immunology</QualifierName>
			<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Inositol
				1,4,5-Trisphosphate Receptors</DescriptorName>
			<QualifierName MajorTopicYN="N">chemistry</QualifierName>
			<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
		</MeshHeading>
	</MeshHeadingList>
	<NumberOfReferences>207</NumberOfReferences>
</MedlineCitation>